Kaleida Health (Kaleida) is an integrated healthcare delivery system that provides acute, skilled nursing, rehabilitative, outpatient, and home healthcare services primarily to the residents of Western New York. The entities consolidated within Kaleida are the Hospital Corporation (consisting of Buffalo General Medical Center, John R. Oishei Children’s Hospital, the Millard Fillmore Suburban Hospital, DeGraff Memorial Hospital, and two hospital based nursing facilities), Visiting Nursing Association of WNY, Inc., VNA Home Care Services, Inc., Upper Allegheny Health System (UAHS), General Physician, P.C. and its subsidiaries (General Physicians), Great Lakes Physicians, P.C. (Great Lakes), several other subsidiaries, and two charitable foundations that raise funds for Kaleida.
The accompanying Schedule of Expenditures of Federal Awards (Schedule) presents the activity of federal award programs administered by Kaleida is in accordance with the requirements of Title 2 U.S. Code of Federal Regulation: Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a select portion of the operations of the Kaleida, it is not intended to and does not present the financial position, changes in net assets, or cash flows of Kaleida. The Schedule is presented on the accrual basis of accounting, except for the following grant: • (COVID 19) Disaster Grants Public Assistance (Presidentially Declared) (ALN 97.036) The grant above is presented based on the amounts obligated for reimbursement approved by Department of Homeland Security Federal Emergency Management Agency from January 1, 2024 to December 31, 2024. Kaleida Health has elected not to charge the 10% de minimis indirect cost rate.
Kaleida has the following obligations outstanding that are insured or coinsured by the U.S. Department of Housing and Urban Development, with a summary of loan activity in 2024. This report summarizes the loan activity for six contracts during the 2024 calendar year. All loans listed are under ALN 14.128. Overall, the combined loan balance began at $247,145,210 on December 31, 2023. Throughout the year, total payments of $13,227,054 were made across the portfolio, and there were no new borrowings. This activity reduced the total outstanding loan balance to $233,918,156 by December 31, 2024. The activity for each specific contract is as follows: Contract 014-13007: This contract has an original loan amount of $189,588,800, but no balance or payment activity was recorded during the 2024 period. Contract 014-10039: Two separate loans are listed under this contract number. The first began the year with a balance of $30,364,312 and was reduced by $2,572,214 in payments, resulting in an end-of-year balance of $27,792,098. The second started at $8,325,768 and was paid down by $881,379, finishing the year at $7,444,389. Contract 014-10047: The loan balance for this contract decreased from $65,141,923 to $61,366,286 after payments totaling $3,775,637 were made. Contract 014-10050: Starting with a balance of $35,723,186, this loan was paid down by $2,157,309, leaving a final balance of $33,565,877. Contract 014-10065: This contract had a beginning balance of $107,590,021. With payments of $3,840,515, the year-end balance was reduced to $103,749,506.